Telos Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.43M Buy
11,336
+436
+4% +$55.2K 0.15% 106
2025
Q1
$1.39M Sell
10,900
-99
-0.9% -$12.7K 0.15% 104
2024
Q4
$1.45M Buy
10,999
+209
+2% +$27.6K 0.16% 104
2024
Q3
$1.57M Sell
10,790
-349
-3% -$50.8K 0.16% 101
2024
Q2
$1.53M Buy
11,139
+177
+2% +$24.3K 0.17% 95
2024
Q1
$1.5M Sell
10,962
-33
-0.3% -$4.53K 0.17% 96
2023
Q4
$1.49M Buy
10,995
+73
+0.7% +$9.92K 0.18% 94
2023
Q3
$1.34M Buy
10,922
+349
+3% +$42.7K 0.19% 97
2023
Q2
$1.34M Buy
10,573
+329
+3% +$41.8K 0.18% 97
2023
Q1
$1.32M Sell
10,244
-203
-2% -$26.2K 0.18% 95
2022
Q4
$1.37M Buy
10,447
+1,098
+12% +$144K 0.2% 96
2022
Q3
$1.09M Buy
9,349
+29
+0.3% +$3.39K 0.18% 99
2022
Q2
$1.1M Buy
9,320
+314
+3% +$36.9K 0.17% 101
2022
Q1
$1.17M Buy
9,006
+802
+10% +$105K 0.15% 106
2021
Q4
$1.25M Sell
8,204
-14,193
-63% -$2.17M 0.16% 102
2021
Q3
$3.62M Sell
22,397
-37
-0.2% -$5.98K 0.5% 70
2021
Q2
$3.67M Buy
22,434
+873
+4% +$143K 0.49% 71
2021
Q1
$3.25M Sell
21,561
-40
-0.2% -$6.02K 0.47% 75
2020
Q4
$3.27M Sell
21,601
-1,366
-6% -$207K 0.5% 69
2020
Q3
$3.11M Sell
22,967
-284
-1% -$38.5K 0.54% 66
2020
Q2
$3.18M Sell
23,251
-993
-4% -$136K 0.62% 61
2020
Q1
$2.61M Buy
24,244
+1,360
+6% +$147K 0.65% 55
2019
Q4
$2.76M Buy
22,884
+638
+3% +$76.9K 0.63% 62
2019
Q3
$2.21M Buy
22,246
+301
+1% +$30K 0.61% 63
2019
Q2
$2.4M Buy
21,945
+816
+4% +$89.1K 0.7% 54
2019
Q1
$2.36M Sell
21,129
-277
-1% -$31K 0.74% 55
2018
Q4
$2.06M Buy
21,406
+976
+5% +$94.1K 0.76% 53
2018
Q3
$2.49M Buy
20,430
+323
+2% +$39.4K 0.8% 51
2018
Q2
$2.21M Sell
20,107
-28,701
-59% -$3.15M 0.76% 54
2018
Q1
$5.21M Buy
48,808
+1,401
+3% +$150K 1.85% 8
2017
Q4
$5.06M Buy
47,407
+2,863
+6% +$306K 1.79% 10
2017
Q3
$4.95M Buy
44,544
+11,142
+33% +$1.24M 1.91% 6
2017
Q2
$3.45M Buy
33,402
+1,608
+5% +$166K 1.38% 16
2017
Q1
$3.11M Buy
31,794
+1,530
+5% +$150K 1.29% 21
2016
Q4
$2.68M Buy
30,264
+24,936
+468% +$2.21M 1.19% 27
2016
Q3
$514K Buy
5,328
+120
+2% +$11.6K 0.24% 99
2016
Q2
$447K Buy
5,208
+954
+22% +$81.9K 0.22% 105
2016
Q1
$370K Buy
4,254
+1,605
+61% +$140K 0.19% 109
2015
Q4
$299K Sell
2,649
-210
-7% -$23.7K 0.16% 124
2015
Q3
$289K Buy
2,859
+156
+6% +$15.8K 0.18% 116
2015
Q2
$332K Buy
2,703
+234
+9% +$28.7K 0.18% 118
2015
Q1
$283K Buy
2,469
+27
+1% +$3.1K 0.17% 119
2014
Q4
$247K Sell
2,442
-5,634
-70% -$570K 0.15% 128
2014
Q3
$737K Sell
8,076
-450
-5% -$41.1K 0.46% 81
2014
Q2
$731K Sell
8,526
-189
-2% -$16.2K 0.45% 84
2014
Q1
$687K Sell
8,715
-825
-9% -$65K 0.48% 80
2013
Q4
$722K Sell
9,540
-120
-1% -$9.08K 0.53% 78
2013
Q3
$675K Sell
9,660
-222
-2% -$15.5K 0.55% 74
2013
Q2
$573K Buy
+9,882
New +$573K 0.5% 78